We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Stem Cell Transplant Repairs Heart

By Biotechdaily staff writers
Posted on 09 Aug 2005
Heart researchers working with a pig model have demonstrated their ability to repair heart attack damage by injecting stem cells taken from another pig's bone marrow directly into the affected area.

Investigators at Johns Hopkins University (Baltimore, MD, USA) completed an animal study that is the prelude to human clinical trials. More...
They reported in the August 1, 2005, online edition of the Proceedings of the [U.S.] National Academy of Sciences that they had restored heart function and repaired damaged heart muscle by 50 to 75% by injecting adult mesenchymal stem cells taken from a pig's bone marrow into the damaged heart tissue of a second pig that had experienced myocardial infarction.

Three main findings were obtained from the current study. First, transplanted cells were prepared from an allogeneic donor and were not rejected, a major practical advance for widespread application of this therapy. Second, the cells could be safely injected by using a percutaneous-injection catheter three days after the myocardial infarction. Third, transplantation of the stem cells resulted in long-term engraftment, profound reduction in scar formation, and near-normalization of cardiac function.

"Ultimately, the goal is to develop a widely applicable treatment to repair and reverse the damage done to heart muscle that has been infarcted, or destroyed, after losing its blood supply,” explained senior author Dr. Joshua Hare, professor of medicine at Johns Hopkins University. "There is reason for optimism about these findings, possibly leading to a first-ever cure for heart attack in humans.”




Related Links:
John Hopkins University

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Prefilled Tubes
Prefilled 5.0ml Tubes
New
Total Laboratory Automation Solution
SATLARS Mini T8
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.